NASP’s comments to FTC’s Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics Workshop
Dec 12, 2017 · Advocacy
NASP represents an industry that focuses on providing high quality patient care first with an added emphasis on outcomes and patient choice. NASP believes that it shares these common goals with the Federal Trade Commission (FTC) and looks forward to partnering with the all governmental agencies to ensure that all patients have access to the medications they need from the pharmacy of their choosing. In furtherance of these shared goals, NASP has submitted the following comments in response to the FTC’s Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics Workshop.